Avalyn Pharma Inc.
www.avalynpharma.comAvalyn is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including idiopathic pulmonary fibrosis and other interstitial lung diseases. Our lead candidate, AP01, is a Phase 2b-ready inhaled formulation of pirfenidone in development for the treatment of pulmonary fibrosis
Read more
Avalyn is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including idiopathic pulmonary fibrosis and other interstitial lung diseases. Our lead candidate, AP01, is a Phase 2b-ready inhaled formulation of pirfenidone in development for the treatment of pulmonary fibrosis
Read more
Country
State
Washington
City (Headquarters)
Seattle
Industry
Employees
11-50
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President
Email ****** @****.comPhone (***) ****-****Board Member
Email ****** @****.comPhone (***) ****-****Member Board of Directors
Email ****** @****.comPhone (***) ****-****Senior Manager , Clinical Data Management
Email ****** @****.comPhone (***) ****-****
Technologies
(2)
Reach decision makers at Avalyn Pharma Inc.
Free credits every month!
Avalyn Pharma Inc. FAQ
Seattle, United States
Biotechnology Research
